C12N

Watch

Stats

Description

MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material A01N 63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N 1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q)

Subclasses

Not Available
Subclass Title
1/00 Micro-organisms, e.g. protozoa; Compositions thereof (medicinal preparations containing material from protozoa, bacteria or viruses A61K 35/66, from algae A61K 36/02, from fungi A61K 36/06; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K 39/00); Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
1/02 Micro-organisms, e.g. protozoa; Compositions thereof (medicinal preparations containing material from protozoa, bacteria or viruses A61K 35/66, from algae A61K 36/02, from fungi A61K 36/06; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K 39/00); Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor Separating micro-organisms from their culture media
1/04 Micro-organisms, e.g. protozoa; Compositions thereof (medicinal preparations containing material from protozoa, bacteria or viruses A61K 35/66, from algae A61K 36/02, from fungi A61K 36/06; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K 39/00); Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor Preserving or maintaining viable micro-organisms (immobilised micro-organisms C12N 11/00)
1/06 Micro-organisms, e.g. protozoa; Compositions thereof (medicinal preparations containing material from protozoa, bacteria or viruses A61K 35/66, from algae A61K 36/02, from fungi A61K 36/06; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K 39/00); Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor Lysis of micro-organisms
1/08 Micro-organisms, e.g. protozoa; Compositions thereof (medicinal preparations containing material from protozoa, bacteria or viruses A61K 35/66, from algae A61K 36/02, from fungi A61K 36/06; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K 39/00); Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor Reducing the nucleic acid content

more results

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
RE45660 Xylanases, nucleic acids encoding them and methods for making and using them Oct 25, 13 Sep 01, 15 BP CORPORATION NORTH AMERICA INC., BP CORPORATION NORTH AMERICA INC.
9,119,860 Agent for use in the case of fructose intolerance Mar 15, 13 Sep 01, 15 VITACARE GMBH & CO. KG, VITACARE GMBH & CO. KG
9,119,888 Methods for cleaning and sterilization of implant tissue ex vivo with shock waves Mar 28, 14 Sep 01, 15 ROYAL GROUP, INC., ROYAL GROUP, INC.
9,119,899 Method and system for treatment of cardiovascular disorders Mar 01, 13 Sep 01, 15 CORMATRIX CARDIOVASCULAR, INC., CORMATRIX CARDIOVASCULAR, INC.
9,120,790 Azaindoles useful as inhibitors of Janus kinases Jul 24, 14 Sep 01, 15 VERTEX PHARMACEUTICALS INCORPORATED, VERTEX PHARMACEUTICALS INCORPORATED
9,120,840 Methods for selective targeting Mar 31, 10 Sep 01, 15 DANISCO US INC., DANISCO US INC. GENENCOR DIVISION
9,120,841 Amphiphilic linear peptidepeptoid and hydrogel comprising the same Dec 31, 12 Sep 01, 15 AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH, AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH
9,120,844 Method for changing conformation of globular proteins May 24, 12 Sep 01, 15 NATIONAL CHENG KUNG UNIVERSITY, NATIONAL CHENG KUNG UNIVERSITY
9,120,849 Nucleic acid amplification controls Oct 30, 07 Sep 01, 15 ZEPTOMETRIX CORPORATION, ZEPTOMETRIX CORPORATION
9,120,863 Nucleic acids encoding antibodies to matrix metalloproteinase 9 Jul 03, 13 Sep 01, 15 GILEAD SCIENCES, INC., GILEAD SCIENCES, INC.
9,120,864 Flowering inhibition May 14, 04 Sep 01, 15 AGRICULTURE VICTORIA SERVICES PTY LTD, AGRICULTURAL VICTORIA SERVICES PTY LTD; AGRESEARCH LIMITED;
9,120,866 DNA sequence and preparation of grass pollen allergen Phl p 4 by recombinant methods Feb 24, 11 Sep 01, 15 MERCK PATENT GMBH, MERCK PATENT GMBH
9,120,867 polypeptides and methods of use Dec 05, 13 Sep 01, 15 FUNDACAO OSWALDO CRUZ, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES;
9,120,868 CelTOS antigen and methods of use thereof Nov 23, 09 Sep 01, 15 THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRATARY OF THE ARMY
9,120,871 Process for preparing FGF21 with low degree of O-glycosylation Jan 20, 11 Sep 01, 15 NOVO NORDISK A/S, NOVO NORDISK A/S
9,120,872 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same Oct 27, 10 Sep 01, 15 REGENTIS BIOMATERIALS LTD., REGENTIS BIOMATERIALS LTD.
9,120,873 Recombinantly produced human factor VIII and IX Aug 21, 09 Sep 01, 15 OCTAPHARMA AG, OCTAPHARMA AG
9,120,875 HSA-related compositions and methods of use Feb 14, 14 Sep 01, 15 MEDIMMUNE, LLC, MEDIMMUNE, LLC
9,120,891 Method for preparing polylactate and copolymer thereof using a mutant microorganism with enhanced polylactate, and the copolymer producing capability thereof Jun 24, 09 Sep 01, 15 LG CHEM, LTD., LG CHEM LTD.; KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY;
9,121,003 Cell culture instrument and cell culture method using the same Sep 05, 08 Sep 01, 15 KITAKYUSHU FOUNDATION FOR THE ADVANCEMENT OF INDUSTRY, SCIENCE AND TECHNOLOGY, KITAKYUSHU FOUNDATION FOR THE ADVANCEMENT OF INDUSTRY SCIENCE AND TECHNOLOGY

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2015/0245,596 MELANOCORTIN RECEPTOR MUTANT MOUSE AND USES THEREOF Sep 17, 13 Sep 03, 15 THE GENERAL HOSPITAL CORPORATION,
2015/0245,572 WATERMELON VARIETY NUN 05506 WMW May 15, 15 Sep 03, 15 NUNHEMS B.V.,
2015/0245,573 Watermelon Variety NUN 05508 WMW May 15, 15 Sep 03, 15 NUNHEMS B.V.,
2015/0245,574 Watermelon Variety NUN 31311 WMW May 15, 15 Sep 03, 15 NUNHEMS B.V.,
2015/0245,576 VARIETY CORN LINE GAV0001 Feb 11, 15 Sep 03, 15 SYNGENTA PARTICIPATIONS AG,
2015/0245,577 VARIETY CORN LINE ID3659 Feb 12, 15 Sep 03, 15 SYNGENTA PARTICIPATIONS AG,
2015/0245,578 VARIETY CORN LINE ID3645 Feb 19, 15 Sep 03, 15 SYNGENTA PARTICIPATIONS AG,
2015/0245,579 VARIETY CORN LINE HID4731 Feb 20, 15 Sep 03, 15 SYNGENTA PARTICIPATIONS AG,
2015/0245,580 VARIETY CORN LINE HID3464 Feb 23, 15 Sep 03, 15 SYNGENTA PARTICIPATIONS AG,
2015/0245,581 VARIETY CORN LINE HID3634 Feb 23, 15 Sep 03, 15 SYNGENTA PARTICIPATIONS AG,
2015/0245,582 VARIETY CORN LINE HID4488 Feb 25, 15 Sep 03, 15 SYNGENTA PARTICIPATIONS AG,
2015/0245,852 SPERM ACTIVATING AGENT AND ACTIVATING METHOD USING SAME Sep 19, 13 Sep 03, 15 NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE,
2015/0246,073 RENAL CELL POPULATIONS AND USES THEREOF Oct 24, 13 Sep 03, 15 REGENMEDTX, LLC,
2015/0246,074 METHODS OF ATTENUATING OPIOID TOLERANCE Mar 02, 15 Sep 03, 15 ,
2015/0246,085 Genetically-Modified Probiotic for Treatment of Phenylketonuria Nov 01, 13 Sep 03, 15 THE SYDNEY CHILDREN'S HOSPITALS NETWORK (RANDWICK AND WESTMEAD),
2015/0246,101 METHODS FOR ALLEVIATING SYMPTOMS OF MULTIPLE SCLEROSIS BASED ON APOAEQUORIN-CONTAINING COMPOSITIONS Sep 27, 13 Sep 03, 15 QUINCY BIOSCIENCE, LLC,
2015/0246,836 SOIL BALL FOR WATER PURIFICATION WITH INCREASED HARDNESS AND MICROBIAL POPULATION Dec 07, 12 Sep 03, 15 KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION,
2015/0246,949 Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor Sep 24, 13 Sep 03, 15 UNIVERSITY OF WASHINGTON,
2015/0246,951 LOCALIZATION AND CHARACTERIZATION OF FLAVIVIRUS ENVELOPE GLYCOPROTEIN CROSS-REACTIVE EPITOPES AND METHODS FOR THEIR USE Mar 16, 15 Sep 03, 15 NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT,
2015/0246,952 MEANS AND METHODS FOR BREAKING NONCOVALENT BINDING INTERACTIONS BETWEEN MOLECULES May 05, 15 Sep 03, 15 ,

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to watch the Technologies/Sub-Technologies.